Beta Drugs Limited Allots Equity Shares Following Conversion of Compulsory Debentures
Beta Drugs Limited announced on May 25, 2026, that its Board of Directors approved the allotment of Equity Shares resulting from the conversion of Compulsory Convertible Debentures (CCDs).The key decision made by the Board was the allotment of 6,65,314 Equity Shares, each valued at ₹10. This allotment stems from the conversion of an equal number of Compulsory Convertible Debentures. The original CCDs had been issued and allotted on November 27, 2024.
The conversion process was executed at a ratio of 1:1. The debentures were associated with the following parties: Healthquad Trust II and Inti Capital VCC - Inti Capital I.
The details of the allotment are summarized below:
| Component | Details |
|---|---|
| Action | Allotment of Equity Shares |
| Number of Shares | 6,65,314 |
| Face Value per Share | ₹10/- |
| Basis of Allotment | Conversion of Compulsory Convertible Debentures |
| CCD Allotment Date | November 27, 2024 |
| Conversion Ratio | 1:1 |
BETA Stock Price Movement
As of 12:19 PM, Beta Drugs Limited shares are shedding 1.00% in live trading, falling to ₹1362.9. The stock has seen 29,537 shares traded, suggesting consistent selling pressure in the market.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.